β‐Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T‐cell acute lymphoblastic leukemia

Abstract Understanding the molecular mechanisms that contribute to the appearance of chemotherapy resistant cell populations is necessary to improve cancer treatment. We have now investigated the role of β‐catenin/CTNNB1 in the evolution of T‐cell Acute Lymphoblastic Leukemia (T‐ALL) patients and it...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Violeta García‐Hernández, David Arambilet, Yolanda Guillén, Teresa Lobo‐Jarne, María Maqueda, Christos Gekas, Jessica González, Arnau Iglesias, Nerea Vega‐García, Inés Sentís, Juan L Trincado, Ian Márquez‐López, Holger Heyn, Mireia Camós, Lluis Espinosa, Anna Bigas
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Springer Nature 2023-01-01
Saila:	EMBO Molecular Medicine
Gaiak:	chemotherapy resistance Kaiso RNA processing T‐ALL β‐catenin
Sarrera elektronikoa:	https://doi.org/10.15252/emmm.202216554
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!